Sectors
RYTM
Rhythm Pharmaceuticals, Inc.
106.13
2 x 77.40
2 x 140.85
bid
ask
-
1.04
0.97%
2 @ 07:30 PM
106.13 +0.00 (0.00%)
| Ytd | -0.85% | |
| 1y | 2.89% |
103.98
day range
108.84
74.50
52 week range
122.20
| Open | 106.01 | Prev Close | 107.17 | Low | 103.98 | High | 108.84 | Mkt Cap | 7.31B |
| Vol | 775.19K | Avg Vol | 758.56K | EPS | -3.12 | P/E | N/A | Forward P/E | -172.77 |
| Beta | 1.97 | Short Ratio | 14.57 | Inst. Own | 114.76% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-03 | 50-d Avg | 109.43 | 200-d Avg | 99.44 | 1yr Est | 140.19 |
| Income Statement | |||
| Total Revenue | 71.26M | ||
| Revenues (USD) | 71.26M | ||
| Cost of Revenue | 8.93M | ||
| Gross Profit | 62.32M | ||
| Operating Expenses | 110.88M | ||
| Research and Development Expense | 43.43M | ||
| Selling, General and Administrative Expense | 67.45M | ||
| Operating Income | -48.55M | ||
| Interest Expense | 4.54M | ||
| Income Tax Expense | 444.00K | ||
| Net Income | -49.30M | ||
| Net Income Common Stock | -50.36M | ||
| Net Income Common Stock (USD) | -50.36M | ||
| Consolidated Income | -49.30M | ||
| Earnings per Basic Share | -0.73 | ||
| Earnings per Basic Share (USD) | -0.73 | ||
| Earnings per Diluted Share | -0.73 | ||
| Earning Before Interest & Taxes (EBIT) | -44.31M | ||
| Earning Before Interest & Taxes (USD) | -44.31M | ||
| Preferred Dividends Income Statement Impact | 1.07M | ||
| Weighted Average Shares | 68.59M | ||
| Weighted Average Shares Diluted | 68.59M | ||
| Balance Sheet | |||
| Cash and Equivalents | 66.22M | ||
| Cash and Equivalents (USD) | 66.22M | ||
| Investments | 265.28M | ||
| Investments Current | 265.28M | ||
| Trade and Non-Trade Receivables | 40.41M | ||
| Current Assets | 426.56M | ||
| Property, Plant & Equipment Net | 2.92M | ||
| Total Assets | 437.27M | ||
| Debt Current | 703.00K | ||
| Total Debt | 3.68M | ||
| Current Liabilities | 123.59M | ||
| Debt Non-Current | 2.98M | ||
| Total Liabilities | 219.97M | ||
| Accumulated Retained Earnings (Deficit) | -1.46B | ||
| Accumulated Other Comprehensive Income | -912.00K | ||
| Shareholders Equity | 102.98M | ||
| Shareholders Equity (USD) | 102.98M | ||
| Assets Non-Current | 10.70M | ||
| Total Debt (USD) | 3.68M | ||
| Goodwill and Intangible Assets | 4.89M | ||
| Inventory | 30.52M | ||
| Liabilities Non-Current | 96.38M | ||
| Trade and Non-Trade Payables | 16.17M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 251.00K | ||
| Net Cash Flow from Financing | -1.16M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 3.48M | ||
| Issuance (Purchase) of Equity Shares | 7.00M | ||
| Net Cash Flow from Investing | 14.01M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | 14.01M | ||
| Net Cash Flow from Operations | -9.15M | ||
| Effect of Exchange Rate Changes on Cash | -217.00K | ||
| Share Based Compensation | 26.06M | ||